Comment Letter
ORIMay9
The document is a formal letter from the Council on Governmental Relations (COGR), an organization representing research universities, addressed to Dr. Kathryn Partin of the Office of Research Integrity (ORI) at the US Department of Health and Human Services. The letter, sent on May 9, 2016, conveys appreciation for ORI's partnership approach and recent engagement with COGR’s Research Complia
COGR_AIRI_Procurement_Survey_June1_2016
The document is a formal letter from the Council on Governmental Relations (COGR) and the Association of Independent Research Institutes (AIRI) addressed to the White House Office of Management and Budget (OMB), reporting the findings of surveys commissioned to assess the administrative and cost impact of a proposed $3,500 micro-purchase threshold for procurement activities at research universitie
RIN 0925-AA53, Docket No NIH-2010-0001
The Council on Governmental Relations (COGR), representing 183 major research universities and affiliated centers, submitted comprehensive comments regarding proposed amendments to Public Health Service (PHS) regulations on promoting objectivity in research funded by the federal government. COGR expresses support for the overarching goal of ensuring research objectivity and transparency around fin
RIN 0925-AA53, Docket No NIH-2010-0001
The Council on Governmental Relations (COGR), representing 183 research universities and affiliated institutions, provides a detailed response to the Public Health Service (PHS) proposed amendments concerning the responsibility of applicants to promote objectivity in research, as outlined in federal regulations. COGR underscores the importance of ensuring research objectivity, favoring regulatory
FINAL_COGR_AAU_Comments_Ethological Petition_USDA_August 2015
The Association of American Universities (AAU) and the Council on Governmental Relations (COGR), representing leading research universities and institutes, submitted a joint response opposing a petition received by the USDA requesting the development of specific "ethologically appropriate" standards for the care of nonhuman primates in research facilities. The petition seeks amendments t
NAS_Part_1_COGR_Response (1)
The document is the Council on Governmental Relations (COGR)'s response to the National Academy of Sciences' report on optimizing federal research regulations and reporting requirements for academic research institutions. COGR broadly expresses support for the report’s recommendations aimed at reducing administrative burden and increasing efficiency in the management of federal research
October_30_2015-_COGR-AAU_Joint_Letter_on_DFARS_Case_2013-D018 (2)
The joint letter from the Association of American Universities (AAU) and the Council on Governmental Relations (COGR) addresses significant concerns regarding the interim Defense Federal Acquisition Regulation Supplement (DFARS) rule, Case 2013-D018, which expands safeguarding and reporting requirements for controlled defense information. The organizations, representing numerous leading U.S. resea
COGR Letter to DOD on COI Requirements
The document represents a comprehensive guide and formal communication pertaining to the procedures, requirements, and regulatory framework for submitting medical research proposals to the U.S. Department of Defense’s Defense Health Program, particularly those managed by the U.S. Army Medical Research and Materiel Command (USAMRMC). It consists of detailed application instructions, policy clarific
Final Comments on NIH Guidelines on Recombinant or Synthetic Nucelic Acid Molecules
The Council on Governmental Relations (COGR), representing 190 research universities and associated medical centers, submitted comments to the NIH Office of Science Policy regarding proposed amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. COGR generally supports the NIH’s intentions to streamline oversight of human gene transfer protocols by
Food_and_Drug_Administration_Clinical_Misconduct_Guidance
The document is a formal comment submitted by the Council on Governmental Relations (COGR) regarding the Food and Drug Administration’s (FDA) interim rule for additional safeguards in clinical investigations involving children and FDA-regulated products. The letter commends the FDA for aligning its regulations (21 CFR Part 50 and 56) with those of the Department of Health and Human Services (DHHS)
